Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mutambanengwe-Jacob MT"'
Autor:
Nematadzira TG; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Murnane PM; Institute for Global Health Sciences, University of California-San Francisco, San Francisco, CA.; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA., Odiase OJ; Hair Analytical Laboratory, University of California-San Francisco, San Francisco, CA; and., Bacchetti P; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA., Okochi H; Hair Analytical Laboratory, University of California-San Francisco, San Francisco, CA; and., Tallerico R; Hair Analytical Laboratory, University of California-San Francisco, San Francisco, CA; and., Chanaiwa VM; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Vhembo T; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Mutambanengwe-Jacob MT; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Louie A; Hair Analytical Laboratory, University of California-San Francisco, San Francisco, CA; and., Chipato T; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe.; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe., Gandhi M; Hair Analytical Laboratory, University of California-San Francisco, San Francisco, CA; and., Stranix-Chibanda L; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe.; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2022 Nov 01; Vol. 91 (3), pp. 237-241. Date of Electronic Publication: 2022 Aug 12.
Autor:
Mutambanengwe-Jacob MT; Department of Pharmacy and Pharmaceutical Sciences, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Maponga CC; Department of Pharmacy and Pharmaceutical Sciences, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe., Amico KR; Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA., Ngara B; Department of Primary Health Care Sciences, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe., Yende-Zuma N; Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, South Africa., Chawana TD; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Nematadzira T; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Gumbo JF; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Goverayi T; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Matibe P; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Malunda BV; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Aizire J; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Taha TE; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Fowler MG; Department of Pathology, The Johns Hopkins Medicine, Baltimore, MD, USA., Stranix-Chibanda L; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.; Child and Adolescent Health Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Publikováno v:
AIDS research and treatment [AIDS Res Treat] 2022 Sep 05; Vol. 2022, pp. 4887202. Date of Electronic Publication: 2022 Sep 05 (Print Publication: 2022).